Mercer Island, WA, United States of America

Yasmin A Chandrasekher

This inventor holds 26 USPTO granted patents and 5 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Cytokine Therapeutics. Top assignee: Zymogenetics, Inc.. Active years: 2003-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasmin A Chandrasekher. Retrieved from https://idiyas.com/inventor/yasmin-a-chandrasekher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 5)

% Patents Active = 50.0

CIPO Patents = 5 (Patent Applications = 10)

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 98(Granted Patents)

Location History:

Mercer Island, WA (US) (2003 - 2014)
Saratoga, CA (US) (2008 - 2014)

Company Filing History:

26 out of 723

Zymogenetics, Inc.

patents

Years Active: 2003-2014

Loading Chart...

Areas of Expertise:

Anti-IL-20 Antibodies

Anti-IL-22RA Antibodies

Inflammation Treatment

Cervical Cancer

Rheumatoid Arthritis

Soluble Receptors

Immunoconjugates

Hybridoma Cell Lines

Interleukin-24

Interleukin-19

Binding Partners

Cytokine Receptor

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8907068 - Anti-IL-20 antibodies and binding partners and methods of using in inflammation (2014-12-09),

2. 8900578 - Anti-IL-TIF antibodies (2014-12-02),

3. 8728469 - Method of treating rheumatoid arthritis using anti-IL-20 antibodies (2014-05-20),

4. 8562984 - Methods of treatment using anti-IL-20 antibodies (2013-10-22),

5. 8536309 - Methods of producing anti-IL-22RA antibodies (2013-09-17),

6. 8524227 - Anti-IL-TIF antibodies (2013-09-03),

7. 8486382 - Method for treating cervical cancer (2013-07-16),

8. 8163286 - Anti-IL-22RA antibodies and binding partners and methods of using in inflammation (2012-04-24),

9. 8133487 - Soluble heterodimeric cytokine receptor (2012-03-13),

10. 8124088 - Methods of treatment using anti-IL-22RA antibodies (2012-02-28),

11. 8003104 - Method for treating inflammation (2011-08-23),

12. 7871616 - Anti-IL-22RA antibodies and binding partners and methods of using in inflammation (2011-01-18),

13. 7855269 - Method for treating inflammation (2010-12-21),

14. 7718172 - Anti-IL-TIF antibodies and methods of using in inflammation (2010-05-18),

15. 7704950 - Methods of using soluble heterodimeric cytokine receptor (2010-04-27),

Title: Innovations in Inflammation: The Patented Work of Yasmin A Chandrasekher

Introduction: Yasmin A Chandrasekher is a prominent inventor based in Mercer Island, WA, known for her significant contributions to the field of biotechnology. With an impressive portfolio of 26 patents, Yasmin has made advancements that are pivotal in understanding and treating inflammatory diseases.

Latest Patents: Among her latest inventions are two notable patents focusing on the blocking activity of specific cytokines involved in inflammatory processes. The first patent involves **Anti-IL-20 antibodies and binding partners**, which aims to obstruct the activity of IL-20 polypeptide molecules. Given that IL-20 plays a crucial role in inflammation and various human diseases, this invention offers methods for antagonizing IL-20 using these antibodies and binding partners. The second patent pertains to **Anti-IL-TIF antibodies**, designed to inhibit the activity of IL-TIF polypeptide molecules that similarly contribute to inflammation. This innovation includes methods for antagonizing IL-TIF in relation to human inflammatory diseases.

Career Highlights: Yasmin's dedication to her research is exemplified by her impactful work at Zymogenetics, Inc., a biopharmaceutical company. Her expertise in creating therapeutics for inflammatory diseases has positioned her as a key figure in the industry. Her patents not only reflect her inventive capabilities but also underscore her commitment to addressing medical challenges associated with inflammation.

Collaborations: Yasmin collaborates with esteemed colleagues such as Wenfeng Xu and Wayne R Kindsvogel. Together, they contribute to advancing scientific research and patentable inventions that hold the promise of improving human health across various inflammatory conditions.

Conclusion: The work of Yasmin A Chandrasekher exemplifies the spirit of innovation in biotechnology. Her patents, particularly in the realm of cytokines and inflammation, are set to play a crucial role in the development of new therapies. As she continues to pave the way for breakthroughs in her field, Yasmin stands out as an influential inventor committed to enhancing our understanding of inflammatory diseases.

Profile summary based on public USPTO records.